- York House Church Lane, Chalfont St Peter,
Gerrards Cross, Buckinghamshire, SL9 9RE - 666-888-0000
- info@tersanpharm.com
- info@tersanpharm.com
- York House Church Lane, Chalfont St Peter,
Gerrards Cross, Buckinghamshire, SL9 9RE - Contact Us
Category: Cancer
May2017
Broadening the reach of Precision Medicine beyond DNA
Initial results of Onco KEM and the WINTHER trial were presented at TAT 2017: 15th International Congress on Targeted Anticancer Therapies, 6-8 Mar 2017, Paris, France. The study demonstrates that the innovative Onco KEM transcriptomic-based decision support system fills a gap left by traditional DNA based targeted therapy, enabling more patients to reach a larger […]
Nov2016
Tersan to present on Combination Therapy in Melanoma with Harvard Medical School (Paris | Nov 29 – Dec 2nd)
Dr Parmentier will present a poster “Combination Therapy in Melanoma: finding biomarkers of synergistic associations using Large Scale Drug Combination Screening and integrated Omics Data Analysis” at the Institut Pasteur International Network Scientific Symposium in Paris on November 30th. The poster showcases the results of a collaborative study between Tersan and the Massachusetts General […]
Sep2016
Tersan Pharmaceuticals Ltd (Paris, Boston) and ValiSeek (London) to collaborate on Phase II Non-small Cell Lung Cancer treatment
Tersan’s advanced data analytics, using its KEM® decision support platform, will help ValiSeek boost success outlook. Tersan® Pharma, a leading digital health Company focused on developing advanced personalized therapeutic decision support systems and a provider of decision support tools and services to accelerate drug development, announces today that it has won a significant contract of […]
Jun2016
WIN 2016 Symposium (Paris | June 27-28)
The WIN 2016 Symposium is the place to be to learn about the latest in cancer research by world class presenters. Come and meet the Tersan team of Dr Mohammad Afshar, Dr Guergova-Kuras, Dr Morley and Dr Vaucouleur.
Jun2015
WIN 2015 Symposium (Paris | 29-30 June)
Dr Mohammad Afshar (Founder and CEO) is presenting our Onco KEM® platform at WIN 2015 on 29 June. Dr. Mariana Guergova-Kuras (CTO) and Dr David Morley (VP Computational Technology) will also be attending the symposium for a fascinating two days of cutting-edge presentations and discussions with global key opinion leaders in cancer research and precision cancer […]
Jun2015
Tersan® Pharma teams together with SIB Swiss Institute of Bioinformatics to discover novel biomarkers for gastric cancer
Leader in clinical big data analytics collaborates with world-class bioinformatics provider in GastricGlycoExplorer consortiumPartnership to develop early detection tools for one of the deadliest cancers Links: Download English PDF | Download French PDF Paris, France, Cambridge, Massachusetts USA, and Geneva, Switzerland, 1 June 2015 – Tersan Pharmaceuticals Ltd, developer of innovative clinical data analysis and diagnostic […]
Jan2015
Nabsys and Tersan Pharmaceuticals Ltd Collaborate to Identify DNA Structural Variants Linked to Targeted Cancers
Nabsys will collaborate with Tersan Pharmaceuticals Ltd to identify structural variations related to breast and prostate cancer and how they affect clinical outcome of patients. Links: Download English PDF Providence, Rhode Island, USA, and Paris, FRANCE – January 12th , 2015 – Nabsys, Inc., a life sciences company pioneering semiconductor-based tools for human genomic analysis in […]
Dec2014
Onco KEM(R) platform for personalized cancer treatment selection
Tersan Pharmaceuticals Ltd releases a video to illustrate its innovative Onco KEM® platform for personalized cancer treatment selection. Onco KEM® intends to accelerate the translation of personalized medicine discoveries into widely available new standards of care for all cancer patients, leading to significantly improved clinical outcomes and a higher quality of life for cancer patients. […]
Oct2014
Tersan Pharmaceuticals Ltd joins the WIN Consortium as official technology partner
Leader in clinical big data analytics collaborates with global stakeholders in personalized cancer medicine. Partnership to accelerate translation of personalized medicine discoveries into widely available new standards of care for all cancer patients. Links: Download English PDF | Download French PDF Paris, France, and Cambridge, Massachusetts USA, 29 October 2014 – Tersan Pharmaceuticals Ltd, developer of […]
Jul2014
Presentations from WIN 2014 Symposium (Paris | June 23 – 24)
Young researchers from Tersan Pharmaceuticals Ltd presented two posters at the recent WIN 2014 Symposium on breakthrough biomarker investigations and combined therapeutic approaches for precision cancer medicine, held in Paris on 23-24 June 2014. “P2.26: Computational biomarker models to predict response to lung cancer treatments from combined molecular data”, Marine Le Morvan, Maria del Pilar Schneider, […]